撒哈拉以南非洲糖尿病相关并发症与多重长期疾病:决定因素与管理策略
该系列文章综合了撒哈拉以南非洲糖尿病相关并发症的现有证据,从多重长期疾病视角审视共享的心代谢风险、心理健康共病及传染病交互作用。广泛晚期诊断和关键心代谢风险因素控制不足导致高并发症率,心理健康障碍和传染病共病进一步加剧易感性。文章提出研究与实践优先方向,包括制定情境化指南、可扩展整合照护模式、强化监测系统及社区共同设计的长期队列。
要点
- 撒哈拉以南非洲糖尿病负担快速增加,微血管、大血管及妊娠相关并发症率上升。
- 晚期诊断和高血压、血脂异常、肥胖、高血糖控制不足是并发症高发的主要驱动因素。
- 心理健康障碍和传染病共病加剧并发症易感性,需多重长期疾病视角管理。
核心结论
- 撒哈拉以南非洲糖尿病并发症负担快速增加,由晚期诊断和心代谢风险因素控制不足驱动,需多层面干预。
研究设计与样本
- 系列文章综合现有证据,从多重长期疾病视角审视撒哈拉以南非洲糖尿病相关并发症。
主要发现
- 微血管、大血管和妊娠相关并发症率上升。
- 广泛晚期诊断和高血压、血脂异常、肥胖、高血糖控制不足导致高并发症率。
- 心理健康障碍和传染病共病进一步加剧易感性。
- 风险因素降低的进展受个体、人际、卫生系统、社会和政策等多层面障碍阻碍。
临床怎么用
- 开发情境化指南、可扩展整合照护模式、强化监测系统及与社区共同设计的长期队列。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Saharan Africa is experiencing a rapid increase in the burden of diabetes, accompanied by increasing rates of microvascular, macrovascular, and pregnancy-related complications. This Series paper synthesises current evidence on diabetes-related complications in sub-Saharan Africa and examines shared cardiometabolic risks, mental health comorbidities, and interactions with communicable diseases through a multiple long-term conditions lens. Widespread late diagnosis and inadequate control of key cardiometabolic risk factors (eg, hypertension, dyslipidaemia, obesity, and hyperglycaemia) drive high complication rates-whereas mental health disorders and infectious disease comorbidities further exacerbate susceptibility. Although risk factor reduction is central to preventing diabetes complications in sub-Saharan Africa, progress is impeded by multilevel barriers spanning individual, interpersonal, health system, societal, and policy domains. To address this growing complexity, we identify priorities for research and implementation, including the development of context-specific guidelines, scalable integrated care models, strengthened surveillance systems, and long-term cohorts co-designed with communities, health-care providers, and policy makers.
引用
- Ikhile D, Seidu S, Omodara D, et al. Diabetes-related complications and multiple long-term conditions in sub-Saharan Africa: determinants and management strategies. Lancet Diabetes Endocrinol. 2026. PMID: 42044653. doi:10.1016/S2213-8587(26)00036-7
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。